Develops and markets the patented Axomera stimulation device for bioelectric pain therapy
Columbus Health Products GmbH
Düsseldorf (Kasernenstr. 1b)New on Amplifa
About Columbus Health Products
Columbus Health Products GmbH is a medical technology company based in Düsseldorf, founded in 1994, that developed the Axomera therapy method. Its core product is the multiple-patented Axomera stimulation device for percutaneous bioelectric direct current stimulation (PBCS), which applies bioelectric fields in a targeted manner to diseased tissue in order to modulate inflammation and influence healing processes. The method has been used clinically since 2014 and is administered in 30-minute sessions without medication. Axomera therapy is used for the conservative treatment of orthopedic, sports medicine and severe pain conditions, including chronic low back pain, tendinopathies, migraines and arthrosis. The device is used in specialized practices and clinics in Germany, Austria, Switzerland and Spain, including the ATOS Clinics; in total, more than 250 practices use the system. The company offers training, peer professional discussions and structured onboarding in practices, as well as rental and usage models (system access, membership, pay-per-use). The Axomera device carries the CE marking as a Class IIa medical device.
- Site
- Düsseldorf
- Processes
- Training/onboarding in practices, Practice finder for patients, Consultation and professional discussions for physicians, Rental/usage model (system access, membership, pay-per-use)
- Materials
- Percutaneous Bioelectric Direct Current Stimulation, Transepithelial Potentials
- Certificates
- CE marking Class IIa (medical device)
- Founded
- 1994 (Link
- Employees
- 2–10 (LinkedIn, ca.
- Industries
- Medical Technology, Pain Therapy, Orthopedics, Sports Medicine, Neurology, Allergology
- 01
Research and development (development by physicians)
- 02
Manufacturing of the Axomera stimulation device
- 03
CE-certified Class IIa medical device
- 04
Training and onboarding in practices
- 05
Rental and usage models
- 06
Clinical support and consultation
Technology and Principle of Operation
Percutaneous Bioelectric Direct Current Stimulation
Method for the targeted application of bioelectric fields to diseased tissue to modulate inflammation and regeneration.
Transepithelial Potentials
Scientific basis of the therapeutic principle based on electric fields that regulate wound healing and cell behavior.
Site
Düsseldorf
DEHeadquarters, development and sales
Industries
Additional services
Reference customers
Quality and Regulatory Approval
The Axomera stimulation device is a Class IIa medical device with CE marking. Clinical use has been in place since 2014, with more than 20,000 treatments per year.
| Evidence | Düsseldorf |
|---|---|
| CE marking Class IIa (medical device) |
Company History
- 1994
Founding of Columbus Health Products GmbH in Germany
- 2008
foundingDate according to the website's JSON-LD
- 2014
Clinical use of Axomera therapy, more than 20,000 treatments per year